Src as a therapeutic target in men with prostate cancer and bone metastases
β Scribed by Fred Saad
- Book ID
- 109055535
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 305 KB
- Volume
- 103
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Prostate cancer (CaP) is unique among all cancers in that when it metastasizes to bone, it typically forms osteoblastic lesions (characterized by increased bone production). CaP cells produce many factors, including Wnts that are implicated in tumorβinduced osteoblastic activity. In thi
## Abstract The poor longβterm outcomes associated with current chemotherapy treatment of patients with advanced gastric cancer suggest a need for novel targeted agents that may confer a better survival benefit. Evidence of mammalian target of rapamycin (mTOR) activation has been demonstrated in pa
## Abstract Knowledge of reβprogramming in cancer cells with metabolic differences from their normal counterparts has resulted in new examination of therapeutic approaches. Several studies of the role of tumor mitochondria in cancer have led to the development of nonβgenotoxic therapies which targe